Thomas P Paulsen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 906 College Ave West, Ladysmith, WI 54848 Phone: 715-532-2345 |
Joel D. Dekrey, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 Lake Ave W, Ladysmith, WI 54848 Phone: 715-532-0203 |
Robert A Nogler, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 906 College Ave West, Ladysmith, WI 54848 Phone: 715-532-2345 |
John L Ziemer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 906 College Ave West, Ladysmith, WI 54848 Phone: 715-532-2345 |
Dr. Richard W Rapp, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Port Arthur Rd, Ladysmith, WI 54848 Phone: 715-532-2471 |
Samantha Jo Runstrom, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 Lake Ave W, Ladysmith, WI 54848 Phone: 920-496-4700 |
Dr. Ganesh Laxman Pawar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 906 College Ave W, Ladysmith, WI 54848 Phone: 715-532-2300 |
Kellsey Mary Provos, DNP, FNP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 906 College Ave W, Ladysmith, WI 54848 Phone: 715-532-2300 |
Dennis Deziel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 College Ave W, Ladysmith, WI 54848 Phone: 715-532-5561 Fax: 715-532-9809 |
News Archive
New proposals to reduce the risk of anaesthetic tubing becoming blocked during operations, were published today. Following 11 similar NHS cases where tubing had become blocked, the Chief Medical Officer, Sir Liam Donaldson set up an Expert Group in July 2002 to look into the issue.
A new federal law took effect Friday, allowing seriously ill or injured college students to keep their parents' insurance for up to a year while they take time off from school.
Mitchell Group, a global manufacturer and distributor of clinically proven and locally inspired cosmetic and beauty products, puts their customer's safety above anything else.
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
› Verified 6 days ago